Newsletter | February 24, 2020

02.24.20 -- 3 Health Tech Trends Shaping The Future Of Clinical Operations

Featured Editorial
3 Health Tech Trends Shaping The Future Of Clinical Operations
By Paola Murphy and Hannah Yee, Halloran Consulting Group

It can be overwhelming to keep up with the rapid pace of health technology advancement; in many ways, it feels like we’re just along for the ride. Let’s fast-forward and take a look into three key areas of innovation that are forcing us to face and embrace a changing technological landscape in clinical research.

Improving Clinical Logistics Outsourcing Relationships
By ISR Reports

In Q3 2019, ISR asked 100 outsourcers of clinical logistics about several different scenarios that could potentially improve outsourcing relationships. Two scenarios were considered “Very Likely – Likely” to improve relationships by three-quarters of respondents: improved technology integration and improvements to project management from both the sponsor and service provider.

Industry Insights
Best Practices For Clinical Trial Labeling Success
Article | By Joanne Staszczyszyn and Kay Kim, Bellwyck Pharma Services

If you are also responsible for the labeling of your trial drug you know that this is sometimes an afterthought or considered the final phase in the process; however, it is the key to the overall success of the trial. Read how a focus on preplanning and following labeling best practices will not only help you get your trial drug ready faster but will also ensure all regulatory requirements have been met and prevent any delays in study start-up.

What Is The Skin Microbiome?
Article | By Stephanie Munroe, Ph.D., Biorasi

The microbiome refers to the genetic material of all the microbes that live on and inside the human body. Using DNA sequencing, researchers are only beginning to uncover links between the microbiome and a host of diseases, including several types of cancer, autoimmune conditions, inflammatory bowel disease, and Crohn’s disease, among others.

Embrace Quality Risk Management To Build A Strong Quality Culture
Article | By Cheryl Abernathy and Bryan Sasbon, Ropack Pharma Solutions

Using quality risk management (QRM) gives a company the ability to maintain compliance while also identifying product issues that could be harmful to the consumers, some being susceptible patients.

The Supply Chain Executive’s Perspective On Single-Supplier CDMOs
Q&A | Thermo Fisher Scientific

A single vendor offers access to a network of experts who can share knowledge about a project as it moves from phase to phase, thus helping to navigate its path toward commercial success. 

The Model-Based Approach: A Better Way To Forecast Enrollment
White Paper | Cytel

Compared to conventional approaches, a model-based approach to enrollment forecasting provides a more realistic assessment of the possible risks and outcomes for any given scenario by accounting for the nonlinearity and randomness of real-life enrollment processes. In addition, a model-based approach offers many more advantages in addition to more realistic expectations.

Fusing Specifications And Design For Data Collection Casebooks With Veeva Vault EDC
White Paper | Veeva Systems, Inc.

Learn how data management teams at ICON, Bioforum, and Vertex Pharmaceuticals are creating the spec and casebook in a single step, reducing study build times and effort by over 50 percent.


The 21st Evolution Summit is an invitation-only, premium summit bringing leading clinical trial executives and innovative suppliers and solutions providers together. Join us at the Meritage Resort & Spa in Napa from March 2 to 4. Key topics for 2020 include: “Effectively Utilizing 21st Century Technologies,” “Patient Recruitment and Adherence,” and “Accelerating Study Start-Up.” Visit our page for more!

Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.

Connect With Clinical Leader: